Dmg Group, LLC Edwards Lifesciences Corp Transaction History

Dmg Group, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$84.3 - $94.31 $33,551 - $37,535	-398 Reduced 8.38%	4,349 $401,000
Q1 2024 Apr 19, 2024	BUY	$72.54 - $95.56 $86,032 - $113,334	1,186 Added 33.31%	4,747 $453,000
Q4 2023 Jan 10, 2024	BUY	$61.71 - $77.76 $9,503 - $11,975	154 Added 4.52%	3,561 $271,000
Q3 2023 Oct 26, 2023	SELL	$69.28 - $93.38 $5,888 - $7,937	-85 Reduced 2.43%	3,407 $236,000
Q2 2023 Jul 13, 2023	SELL	$81.41 - $94.33 $1,383 - $1,603	-17 Reduced 0.48%	3,492 $329,000
Q1 2023 Apr 24, 2023	BUY	$74.26 - $84.51 $55,397 - $63,044	746 Added 27.0%	3,509 $288,000
Q4 2022 Feb 06, 2023	SELL	$68.3 - $87.44 $2,390 - $3,060	-35 Reduced 1.25%	2,763 $205,000
Q3 2022 Oct 27, 2022	BUY	$82.37 - $107.29 $14,661 - $19,097	178 Added 6.79%	2,798 $239,000
Q2 2022 Aug 09, 2022	BUY	$86.5 - $128.27 $3,546 - $5,259	41 Added 1.59%	2,620 $253,000
Q1 2022 Apr 25, 2022	SELL	$101.96 - $128.34 $199,535 - $251,161	-1,957 Reduced 43.14%	2,579 $305,000
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $482,494 - $592,764	4,536 New	4,536 $462,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Dmg Group, LLC with notifications on news.